BOT 2.60% 37.5¢ botanix pharmaceuticals ltd

Bot Chart, page-7243

  1. 2,087 Posts.
    lightbulb Created with Sketch. 1487


    The Japan evidence is that it sells, and the US is a potential 3 x times the market. US Insurers are prepared to pay over $600/script (they already do with other, lesser, products). 23k scripts x 12 months x $600 x 3 times the population - you're looking at $500m per annum! What happens when you extend to Europe, Oceania, Africa, etc?
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.